(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

SIR-ACTIN

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

SIR-ACTIN

ST13

US500000079388948

Class

1, 5

Filing

79388948

Registration

7656601

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

30

Latest update

04/03/2026

Classification

Registered

Trademark type

Word

Nice classes

1, 5

Filing date

11/08/2023

Registration date

01/21/2025

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

01/21/2025

Last transaction

04/03/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

25

Owner location

CH

Examiner

BUTLER, ANDREA P

Law office

T50

Current location

FILE REPOSITORY (FRANCONIA)

Holders and representatives

Holders

Spirochrome AG

Representatives

Andrew M. Smith Resonate IP, LLC

Technical classification

Nice Classes

Class 1Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Biological preparations for use in industry and science; diagnostic preparations for science or research purposes; reagents for research purposes; diagnostic reagents for science or research purposes; diagnostic reagents for in vitro or in vivo use for biochemistryclinical chemistrymicrobiology and cellular biology; reagents for in vitro or in vivo use in laboratoriesexcept for medical or veterinary use; fluorescent chemical preparations used as fluorescent markers for marking proteins in cells for scientific purposes; chemical preparations for marking biomolecules; biomolecules containing reagents intended for scientific research purposes; fluorescent chemical preparations for use in microscopy; fluorescent biomolecules for use in microscopy

Class 5

diagnostic agents for medical purposes; in-vitro diagnostic preparations for medical use; diagnostic kits containing chemical products in the nature of diagnostic agentspreparationssubstances for medical use; kits comprising diagnostic agentspreparations and substances used for diagnostic purposes and medical use; diagnostic test reagents for medical or veterinary use; diagnostic reagents for medical or veterinary use; biological and chemical reagents for medical or veterinary use; diagnostic biomarking reagents for medical use; medical diagnostic reagents and assays for testing bodily fluids; diagnostic reagents and contrast agents for medical use; contrast media for in-vivo imaging

Publications

History of USPTO decisions and trademark events.

30 publications found

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

08/23/2025

FICS

FINAL DISPOSITION NOTICE SENT TO IB

08/05/2025

FIMP

FINAL DISPOSITION PROCESSED

08/05/2025

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

07/26/2025

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

07/07/2025

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

07/07/2025

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

04/22/2025

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

01/21/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

01/21/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

12/03/2024

PUBO

PUBLISHED FOR OPPOSITION

12/03/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

11/27/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

11/06/2024

XAEC

EXAMINER'S AMENDMENT ENTERED

11/05/2024

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

11/05/2024

GNEA

EXAMINERS AMENDMENT E-MAILED

11/05/2024

CNEA

EXAMINERS AMENDMENT -WRITTEN

11/05/2024

DOCK

ASSIGNED TO EXAMINER

10/15/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

09/26/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

09/26/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

09/26/2024

RFNT

REFUSAL PROCESSED BY IB

08/17/2024

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

07/29/2024

RFRR

REFUSAL PROCESSED BY MPU

07/29/2024

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

07/02/2024

CNRT

NON-FINAL ACTION WRITTEN

07/01/2024

DOCK

ASSIGNED TO EXAMINER

06/17/2024

MAFR

APPLICATION FILING RECEIPT MAILED

02/16/2024

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

02/12/2024

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

02/09/2024

Continuous trademark protection

Get notified about every new filing that threatens SIR-ACTIN or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.